Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protopic Safety and Efficacy in Atopic Dermatitis
NCT00106496Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Oct 2004
- Primary completion
- Jul 2006
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Envarsus XR in atopic dermatitis (AD), sponsored by Astellas Pharma. Started Oct 2004; status: completed.
02
Drugs
Envarsus XR
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00106496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106496.